SCHEDULE 13G/A

Rocket Pharmaceuticals Inc

Common Stock, $0.01 par value per share · CUSIP: 77313F106

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Maverick Capital, Ltd.

  Shares: 8,363,813.00 · Class: 7.8%

• Maverick Capital Management, LLC

  Shares: 8,363,813.00 · Class: 7.8%

• Lee S. Ainslie III

  Shares: 8,363,813.00 · Class: 7.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.